The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.
This article was originally published on MedicalXpress.com
FDA approves first new non-opioid pain pill in decades
You may also be interested in:
The Latest
Microneedling Services in Edmonton: Benefits, Treatment Cost, and How It Works
Microneedling is a revolutionary skincare treatment that has gained popularity in recent years due to its numerous benefits, including reducing the appearance of scars, wrinkles, and acne, and promoting collagen production. Edmonton, the bustling capital […]
The Latest
Exploring Attachment Styles and How They Affect Adult Relationships
Do you want to know more about attachment types and adult relationships? If so, you’ve come to the right place! In this blog, we’ll examine how different attachment styles impact our relationships and how understanding […]
The Latest
Avoiding Common Relationship Mistakes for a Happier Love Life
Fostering a rewarding and fulfilling relationship is no easy task. You and your partner are only human, and, as the saying goes, you are going to make mistakes. However, learning the common relationship mistakes and […]
Read More:
-
At the height of the COVID-19 pandemic, firearm violence surpassed motor vehicle accidents as the leading cause of death among US children. A new study [...]
-
New Curtin University research has revealed child food insecurity in developed countries is not solely driven by poverty but is also strongly influenced by factors [...]
-
Researchers at Oregon Health & Science University’s Center for Mental Health Innovation have discovered that maternal diet during pregnancy, specifically during the third trimester, may [...]
